miR-203a-A是调节癌症特征和治疗反应的多面调节器
Priyajit Biswal1, Anthony Lalruatfela1, Subham Kumar Behera1
1RNAi and Functional Genomics Lab., Department of Life Science, National Institute of Technology, Rourkela, Odisha, India.
IUBMB life
|October 4, 2023
概括
微RNAs (miRNAs),特别是miR-203a,是癌症发展和进展的关键调节者. 本综述强调了miR-203a在癌症特征中的作用,其作为生物标志物的潜力,以及其对化疗反应的影响.
科学领域:
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
- 在瘤学瘤学.
背景情况:
- 微RNAs (miRNAs) 是调节基因表达的小型非编码RNAs.
- 失调的miRNA表达与人类疾病,特别是癌症有关.
- miR-203a是各种癌症类型中经常发生变化的miRNA.
研究的目的:
- 审查miR-203a在癌症中的多方面的作用.
- 探索miR-203a对癌症特征和瘤发生的影响.
- 评估miR-203a在癌症诊断,预后和治疗中的潜力.
主要方法:
- 在癌症中调查miR-203a的研究的文献综述.
- 对miR-203a的调节机制和基因的分析.
- 检查miR-203a在癌症特征和化学抵抗中的参与.
主要成果:
- miR-203a调节癌症的关键特征,包括扩散,入侵,转移,细胞死亡和血管生成.
- 根据癌症类型,miR-203a作为瘤抑制剂或瘤基因起作用.
- 在生物流体中可以检测到miR-203a,这表明生物标记物的潜力.
- miR-203a增强了对几种化疗剂的敏感性.
结论:
- miR-203a是癌细胞行为和瘤发生的关键调节剂.
- miR-203a作为诊断和预后生物标志物具有前途.
- 向miR-203a可能会提高癌症治疗中的化疗疗效率.
更多相关视频
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K


